Collection of Plasma Samples From Individuals Initiating Therapy With Entecavir or Tenofovir for Chronic Hepatitis B Virus Infection for the Clinical Evaluation of the Aptima HBV Quant Assay
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Entecavir (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Hologic
- 22 Mar 2017 Planned End Date changed from 1 Sep 2018 to 1 Mar 2018.
- 11 May 2016 Planned End Date changed from 1 Mar 2016 to 1 Sep 2018.
- 11 May 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Sep 2018.